The year in cardiology 2016: heart failure. - Wikidata - awgldk - TriplyDB

The year in cardiology 2016: heart failure.

The year in cardiology 2016: heart failure.

http://www.wikidata.org/entity/Q53798859

about

The year in cardiology 2016: heart failure.

http://www.wikidata.org/entity/Q53798859

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The year in cardiology 2016: heart failure.

@en

The year in cardiology 2016: heart failure.

@nl

type

label

The year in cardiology 2016: heart failure.

@en

The year in cardiology 2016: heart failure.

@nl

prefLabel

The year in cardiology 2016: heart failure.

@en

The year in cardiology 2016: heart failure.

@nl

P1433

Q53798859-D307D207-0DC2-4D4B-ABE7-27EA6CF76FFF

P1476

Q53798859-A0EBC682-082B-4A23-82F1-B08988821EB9

P2860

Q53798859-03468930-EC5D-41EB-85D6-20B324A3266D

Q53798859-07CC44A1-6AE1-475F-9B24-9280A59498E1

Q53798859-11DC3338-FFCA-4A05-8E5B-8DD32BFC76F3

Q53798859-15C2A906-16CA-4E65-9A75-474719818585

Q53798859-278064D9-BB24-47F8-A2F2-F263003D3B8F

Q53798859-27A86015-DF43-42AA-95DD-EEDF05578DA7

Q53798859-2BDE6388-037E-460F-BF78-A8BAFF114BA3

Q53798859-2BF9CC00-C7D5-4404-ACF1-836C883E23EC

Q53798859-3FB3E7C3-62E7-4154-98F0-B7FA01A570C1

Q53798859-51755CC3-3D8A-493B-B201-B604894B4520

P304

Q53798859-1A14DB15-C521-417E-A10B-10921FA2A1CE

P31

Q53798859-850E1B59-AFDC-4872-8A4B-EBCD7EFDE67C

P356

Q53798859-DBDF0673-E5DF-4573-B3C7-C6DFA092EB7B

P433

Q53798859-1A222D22-C8C6-472D-9A2E-283B08FA03BD

P478

Q53798859-3374C24E-EA00-42D1-A68E-ACB4A9BC21FB

P50

Q53798859-30410D7D-F6BE-48DA-AEE9-ECEC983EC8AC

Q53798859-7CBBD8C7-EBE2-48FA-91F1-5C3A52D8011E

P577

Q53798859-0149E5C9-5D17-4352-AF3E-4417061537D1

P698

Q53798859-79345A49-3F2D-4641-AEB9-4D17A6671D7C

P921

Q53798859-A46385ED-D2E5-464B-9B6C-898067E25B5B

P356

P1433

European Heart Journal

P1476

The year in cardiology 2016: heart failure.

@en

P2860

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial.

Angiotensin-neprilysin inhibition versus enalapril in heart failure

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors.

Sodium zirconium cyclosilicate in hyperkalemia.

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribut

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

P304

705-711

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHW638

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

Aldo P Maggioni

Frank Ruschitzka

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28043977

http://www.w3.org/2001/XMLSchema#string

P921